Sleep Vivos Therapeutics gets FDA clearance for novel sleep apnea treatment device The company says its study showed a 98% satisfaction rate for the daytime-nighttime appliance Rowan DunneJanuary 4, 2023
Gold Orea Mining acquires Nordgold’s 55 per cent stake in French Guiana gold mine Orea Mining is a gold explorer working in the prospective and underexplored Guiana Shield, South America Joseph MortonJanuary 4, 2023
Gold Osisko Development foresees $901M cash flow from Cariboo gold project in central B.C. The company completed a feasibility study for the project and expects to produce 1.8M oz of gold over 12 years Rowan DunneJanuary 4, 2023
Mining U.S. government gets backlash from Nevada Indigenous groups over controversial lithium project The government is facing lawsuits from the Reno-Sparks Indian Colony and several others over its approval of the Thacker Pass mine Rowan DunneJanuary 3, 2023
Technology WeTrade Group receives Strongest Potential IPO of the Year Award for 2022 WeTrade Group is a SaaS based company offering offering services and tools for companies in multiple different sectors Joseph MortonJanuary 3, 2023
Psychedelics New York legislators introduce bill to legalize natural psychedelics Bill A00114 would legalize adult possession and use of ibogaine, mescaline, psilocybin and psilocin Natalia Buendia CalvilloJanuary 3, 2023
Gold Zacatecas Silver mineral resource estimate shows high grade gold and silver The project is in the Fresnillo silver belt in the Mexican Zacatecas state, which has produced over 6.2 billion ounces of silver to date Joseph MortonJanuary 3, 2023
Sleep Movano Health unveils wearable smart ring for women The 'Evie' device identifies sleep patterns and trends throughout a woman's menstrual cycle Rowan DunneDecember 30, 2022
Technology NWTN delivers first range-extended electric vehicles to Abu Dhabi Range extending technology adds battery time between charges, which can be useful for long trips Joseph MortonDecember 30, 2022
Psychedelics Biomind Labs develops sublingual psychedelic drug to treat Alzheimer’s The under-the-tongue drug candidate will be studied in a Phase II clinical trial prior to commercialization Rowan DunneDecember 30, 2022